Previous symbols: SUR, HRINS. Aliases: HI, PHHI, SUR1, MRP8, ABC36, HHF1, TNDM2.
ABCC8 (ATP binding cassette subfamily C member 8) is named by 4 disorder entries, including Congenital Isolated Hyperinsulinism; and Hyperinsulinemic Hypoglycemia.
ai-gene-review gives SUR1's core molecular functions as ATP hydrolysis activity; and potassium channel regulator activity, at the plasma membrane, acting in potassium ion transmembrane transport; and regulation of insulin secretion.
The causative records with a germline variant origin are Congenital Isolated Hyperinsulinism; and Hyperinsulinemic Hypoglycemia. In Congenital Isolated Hyperinsulinism the gene sits on KATP Channel Loss of Function; in Hyperinsulinemic Hypoglycemia it also sits on Focal Lesion Formation by Paternal K-ATP Variant and Somatic 11p15 Maternal Loss. Diabetes mellitus records the gene as causative, with ClinGen rating it definitive for monogenic diabetes.
The KB and ai-gene-review share 2 GO process terms: potassium ion transmembrane transport; and regulation of insulin secretion. ClinGen classifies ABCC8 for 4 diseases; those with no matching dismech entry are hyperinsulinemic hypoglycemia, familial, 1; and hyperinsulinism. The hyperinsulinism entries cover this biology, but they map HHF1 only as a narrower match and do not bind the broader hyperinsulinism class, so neither ClinGen tier is recorded on them.
Underlined values are claims re-computed from the knowledge base each time this page is built. The tables below are the source of truth.
ai-gene-review has this gene at status DRAFT; the description is shown only once the review is complete. Read the draft upstream.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Congenital Isolated Hyperinsulinism | causative germline |
mechanism: KATP Channel Loss of Function
subtype: KATP-HI Diffuse; KATP-HI Focal
scoped to subtype: KATP-HI Diffuse
|
| Diabetes mellitus | causative |
mechanism: Monogenic Beta-Cell Dysfunction
subtype: PNDM3; TNDM2; maturity-onset diabetes of the young, type 12
scoped to subtype: PNDM3, TNDM2, monogenic diabetes
|
| Hyperinsulinemic Hypoglycemia | causative germline |
mechanism: Focal Lesion Formation by Paternal K-ATP Variant and Somatic 11p15 Maternal Loss; K-ATP Channel Loss of Function
subtype: Atypical HI; Diazoxide-Unresponsive HI; Diffuse HI; Focal HI
|
| Placental Abruption | susceptibility |
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| hyperinsulinism MONDO:0002177 | AD | Definitive 2026-01-20 |
no dismech entry |
| hyperinsulinemic hypoglycemia, familial, 1 MONDO:0009734 | AR | Definitive 2026-01-20 |
no dismech entry |
| pulmonary arterial hypertension MONDO:0015924 | AD | Moderate 2025-03-12 |
Pulmonary_hypertension
not named
|
| monogenic diabetes MONDO:0015967 | SD | Definitive 2022-07-24 |
Diabetes mellitus
causative
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.